-+ 0.00%
-+ 0.00%
-+ 0.00%

Procept BioRobotics Q1 net loss widens 28% to $31.6 million; revenue rises 20% to $83.1 million

PUBT·04/29/2026 20:14:39
Listen to the news
Procept BioRobotics Q1 net loss widens 28% to $31.6 million; revenue rises 20% to $83.1 million
  • Procept BioRobotics posted a net loss of USD 31.6 million in first-quarter 2026, widening from a year earlier.
  • Revenue climbed 20% to USD 83.1 million.
  • Gross margin improved to about 65% from 64% a year earlier.
  • Aquablation users completed about 12,200 U.S. procedures, up about 30%, while U.S. install base rose 40% to 765 systems.
  • Procept maintained full-year 2026 revenue outlook of USD 390 million to USD 410 million, targeting U.S. procedure growth of 39% to 48%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604291603PRIMZONEFULLFEED9709794) on April 29, 2026, and is solely responsible for the information contained therein.